📣 Exciting update from the Nephrolab :koeln: Cologne:
This preprint marks our debut in the BBS research area, presenting work of Emilia Kieckhöfer on cystic kidney disease in Bbs8 and potential mechanisms.
A heartfelt thank you to Helen May-Simera and her team, along with all other contributors, for their invaluable support!
Kia ora good mastodon folk. A rare plug from me for you to fill something in. The Rare Disorders NZ survey is open now and we need as many respondents as possible.
If you have a rare disorder, or care for someone who does, please fill this out. The survey results have real significance, and are used to influence decision making across government.
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K.
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
I'm thinking about #PKU supplements, our special drink, medicine... What ever you call it!
I'm changing to a new type & wondering what affects your choice of supplement. Is it just the taste, or how easy it is to get, to take, to carry, etc.?
🔎Can you improve #ClinicalTrials for #RareDiseases?
🧬The biology of rare diseases is poorly understood
🩺Tiny numbers of patients make it hard to run clinical trials
➡️Apply now to create trial designs that speed development of #RareDisease treatments
👉https://europa.eu/!CYj638
#Introductions Hi Mastodon community! I am a MRC Investigator and group leader at the MRC Human Genetics Unit at the University of Edinburgh. Very glad to be here...
A certified '#cellbiology on an organismal scale' fanatic- we believe seeing is believing! We ❤️ hacking ways to 'see' biology happen in real time across scales in health and disease!
Imaging addict. Genome wrangler. Developmental biologist at heart.